US 8420664
A3 adenosine receptor allosteric modulators
granted A61KA61K31/00A61K31/4745
Quick answer
US patent 8420664 (A3 adenosine receptor allosteric modulators) held by THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. HEALTH & HUMAN SERVICES
- Grant date
- Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/00, A61K31/4745, A61P, A61P1/04